4//SEC Filing
Cavanaugh Sarah 4
Accession 0001415889-25-016260
CIK 0000744218other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:22 PM ET
Size
5.9 KB
Accession
0001415889-25-016260
Insider Transaction Report
Form 4
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
Transactions
- Award
Incentive Stock Option (right to buy)
2025-06-05+78,000→ 78,000 totalExercise: $19.53From: 2026-06-05Exp: 2035-06-05→ Common Stock (78,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001709113
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:22 PM ET
- Size
- 5.9 KB